Apr 15
12:00 pm | Toronto/Virtual

Topic teaching: Pediatric and Neonatal Transfusion Practice

Presented by Dr. Sarah Tehseen Assistant Professor Paediatric Haematology/Oncology Royal University Hospital, Saskatoon Learning objectives Developmental hematologic differences relevant for transfusion Transfusion medicine laboratory testing for neonates and infants Blood Component administration

Apr 8
12:00 pm | Toronto/Virtual

Topic teaching: Serologic workup at an immunohaematology reference lab

Presented by Dr. Akash Gupta Medical Officer Canadian Blood Services Learning objectives Review the principles behind red cell agglutination Discuss common and advanced serologic techniques Develop an approach to positive antibody screen investigations Note: The session is a self-approved group

Apr 1
12:00 pm | Toronto/Virtual

Topic teaching: Paediatric massive haemorrhage protocol

Presented by Dr. Valérie Arseneault Pediatric Hematologist-Oncologist CHU Sainte-Justine Learning objectives Discuss key physiological differences in pediatrics compared to adults regarding massive hemorrhage and transfusion. Understand the definition of massive hemorrhage protocol and activation

Mar 18
12:00 pm | Toronto/Virtual

Journal club: Innovative transfusion strategies for blood deserts in disaster settings

Presented by Dr. Ali Seyed Tabatabaey Transfusion Medicine Physician Trainee University of Toronto Learning objectives Understanding definitions of "Mass Casualty Incident" and "blood desert" Understand stages of response to disasters Familiarization with The WHO guidance on managing blood supplies

Mar 11
12:00 pm | Toronto/Virtual

The Interesting Story that a Mixed Field Can Tell: Pheno-to-Geno Finds & Clues in Acquired Loss of Heterozygosity

Presented by Dr. Christine Cserti Gazdewich Associate Medical Director - Blood Transfusion Laboratory & Consultant Hematologist University Health Network Learning objectives Recognize the power of a mixed field RHD grouping problem to reveal insights on somatically acquired clonal marrow changes

Mar 4
12:00 pm | Toronto/Virtual

Journal club: Associations between blood donors, component modifications, and the alloimmunization of transfusion recipients

Presented by Dr. Thamer Albegamy Transfusion Medicine Physician Trainee University of British Columbia Learning objectives 1.Understand the impact of blood donor characteristics on recipient alloimmunization risk. 2.Evaluate the role of blood component modifications in alloimmunization prevention. 3

Feb 11
12:00 pm | Toronto/Virtual

Topic teaching: The Hype and Hope of Gene Therapy for Patients with Sickle Cell Disease

Presented by Dr. Kevin H.M. Kuo, MD, MSc, FRCPC Associate Professor Division of Hematology, Department of Medicine, Faculty of Medicine, University of Toronto Associate Professor (status) Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto

Feb 4
12:00 pm | Toronto/Virtual

Topic teaching: Artificial Intelligence and it's applications to clinical medicine and/or medical research

Presented by Dr. Adam Yan Pediatric Oncology Attending | Oncology Informatics Lead The Hospital for Sick Children Learning objectives Understand what a clinical deployment environment (CDE) for ML is Introduce SickKids PREDICT, an operational machine learning program as an example of a CDE Discuss

Jan 28
12:00 pm | Toronto/Virtual

Journal club: Journal Club: Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage

Presented by Dr. Sebastian Vuong Transfusion Medicine Physician Trainee McMaster University Learning objectives Brief review of recent trials exploring transfusion thresholds in traumatic brain injury. Appreciate the pathophysiologic considerations of intracranial hemorrhage and cerebral oxygenation

Jan 14
12:00 pm | Toronto/Virtual

Topic teaching: Drug-induced hemolytic anemia

Presented by Dr. Sue Johnson Director of Clinical Education Director, Specialist in Blood Banking (SBB) Program Versity Learning objectives List pretransfusion test results (antibody detection test/screen, direct antiglobulin test and eluate) consistent with drug-induced Immune hemolytic anemia